Search - tctmd.com

Displaying 21 - 40 of 1132

Sort: Relevancy | Date

News Features

Run, Walk, Bike: Doctors Open Up About Their Own Heart-Healthy Exercise Habits

Michael O'Riordan

November 11, 2016

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Todd Neale

November 08, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) from: EXCEL and NOBLE

Presenter: Yves R. Louvard, John D. Puskas, Davide Capodanno

November 01, 2016

Presentation TCT 2016

Case Resolution: What Was Done

Presenter: John A. Bittl, David J. Maron, Kishore J. Harjai

November 01, 2016

Presentation TCT 2016

The Case for Surgery

Presenter: Michael A. Borger, Vinod H. Thourani, Martin Misfeld

November 01, 2016

Presentation TCT 2016

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Presenter: Sanjay Kaul, Jeffrey J. Popma, John D. Puskas

November 01, 2016

Presentation TCT 2016

When Equipoise Exists: Is Unbiased, Informed Consent Possible?

Presenter: John A. Bittl, David J. Maron, John A. Spertus

November 01, 2016

Presentation TCT 2016

The Case for Transcatheter Therapy

Presenter: Michael A. Borger, Vinod H. Thourani, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

The Case for Multivessel PCI

Presenter: John A. Bittl, David J. Maron, Sripal Bangalore

November 01, 2016

Presentation TCT 2016

The Case for CABG

Presenter: John A. Bittl, David J. Maron, A. Pieter Kappetein

November 01, 2016

Presentation TCT 2016

The Case for a Trial of Medical Therapy

Presenter: John A. Bittl, David J. Maron, Michael E. Farkouh

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did We Revascularize This Patient?

Presenter: John D. Puskas, Gregg W. Stone, Michael E. Halkos

November 01, 2016

Presentation TCT 2016

Case Introduction: How Would You Revascularize This Patient?

Presenter: John D. Puskas, Gregg W. Stone, Michael E. Halkos

November 01, 2016

Presentation TCT 2016

Announcing the NIH-sponsored HYBRID Revascularization Trial

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations

Presenter: John D. Puskas, Gregg W. Stone, John S. Douglas Jr

November 01, 2016

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

Advertisement

Run, Walk, Bike: Doctors Open Up About Their Own Heart-Healthy Exercise Habits

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Highlights (and my Interpretations) from: EXCEL and NOBLE

Case Resolution: What Was Done

The Case for Surgery

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

When Equipoise Exists: Is Unbiased, Informed Consent Possible?

The Case for Transcatheter Therapy

The Case for Multivessel PCI

The Case for CABG

The Case for a Trial of Medical Therapy

Case Conclusion: How Did We Revascularize This Patient?

Case Introduction: How Would You Revascularize This Patient?

Announcing the NIH-sponsored HYBRID Revascularization Trial

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content